|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2018.01) |
| A61K 35/17 | (2015.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K2317/622 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C12N2510/00 | (2013.01) | ||
| C12N 5/0636 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K 16/2866 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2319/33 | (2013.01) | ||
| A61K2039/804 | (2018.08) | ||
| A61K 39/4611 | (2023.05) | ||
| A61K2239/31 | (2023.05) | ||
| A61K2239/38 | (2023.05) | ||
| A61K 39/4631 | (2023.05) | ||
| A61K 39/464412 | (2023.05) | ||
| A61K2239/48 | (2023.05) |
| (11) | Number of the document | 3886875 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19824224.0 |
| Date of filing the European patent application | 2019-11-29 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/063889 |
| Date | 2019-11-29 |
| (87) | Number | WO 2020/113194 |
| Date | 2020-06-04 |
| (30) | Number | Date | Country code |
| 201862774164 P | 2018-11-30 | US | |
| 201862776415 P | 2018-12-06 | US | |
| 201962847926 P | 2019-05-14 | US | |
| 201962854945 P | 2019-05-30 | US | |
| 201962890600 P | 2019-08-22 | US | |
| 201962931204 P | 2019-11-05 | US |
| (72) |
ALBERTSON, Tina , US
GARCIA, Jacob Randolph , US
GILBERT, Mark , US
LI, He , US
SUTHERLAND, Claire , US
TREDE, Nikolaus Sebastian , US
|
| (73) |
Juno Therapeutics, Inc. ,
400 Dexter Ave. N
Suite 1200, Seattle, WA 98109-4703,
US
|
| (54) | METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY |
| METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY |